دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis
Ilon C. Weinstein a , Xian Wu b , Alexander Hill a , Donald Brennan a , Danly Omil-Lima b , Spyridon Basourakos c , Aaron Brant c , Patrick Lewicki c , Bashir Al Hussein Al Awamlh d , Daniel Spratt e , Leonardo Kayat Bittencourt f , Doug Scherr c , Nicholas G. Zaorsky e , Himanshu Nagar g , Jim Hu c , Christopher Barbieri c , Lee Ponsky b , Andrew J. Vickers h,y, Jonathan E. Shoag
doi : 10.1016/j.euo.2023.04.004
Volume 6, Issue 4, August 2023, Pages 355-365
Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities
Bele´n Caramelo a,b , Sladjana Zagorac c , Sonia Corral c , Miriam Marque´s c,d,*, Francisco X. Real
doi : 10.1016/j.euo.2023.02.011
Volume 6, Issue 4, August 2023, Pages 366-375
Cancer Associated Fibroblasts: An Understudied but Critical Component of the Tumor Microenvironment in Urothelial Cancer
Sean Clark-Garvey a , Jeffrey S. Damrauer b , Matthew I. Milowsky
doi : 10.1016/j.euo.2023.05.005
Volume 6, Issue 4, August 2023, Pages 376-377
A Systematic Review of Intra- and Postoperative Complication Reporting and Grading in Urological Surgery: Understanding the Pitfalls and a Path Forward
Christopher Soliman a,*, Niranjan J. Sathianathen a , Benjamin C. Thomas a , Gianluca Giannarini b , Nathan Lawrentschuk a , Patrick Y. Wuethrich c , Philip Dundee a , Rajesh Nair d , Marc A. Furrer
doi : 10.1016/j.euo.2023.01.002
Volume 6, Issue 4, August 2023, Pages 378-389
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini a , Thomas Zilli b , Antoine Giraud a , Gianluca Ingrosso c , Mario Di Staso d , Fabio Trippa e , Pascal Pommier f , Emmanuel Meyer g , Giulio Francolini h , Ulrike Schick i , David Pasquier j , Jean Marc Cosset k , Nicolas Magne l , Etienne Martin m , Ke´mara Gnep n , Raphaelle Renard-Penna o , Ewen Anger n , Ve´rane Achard b , Nicolas Giraud a , Cynthia Aristei p , Victoria Ferrari q , Corentin Pasquier r , Hind Zaine j , Osman Osman f , Beatrice Detti h , Tanguy Perennec s , Inga Mihoci d , Ste´phane Supiot s , Igor Latorzeff t , Paul Sargos a,*
doi : 10.1016/j.euo.2023.02.013
Volume 6, Issue 4, August 2023, Pages 390-398
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier a,b,*, Thomas Lacornerie c , Ste´phane Supiot d , Pascal Pommier e , Magali Quivrin f , Jean-Marc Simon g , Genevie`ve Loos h , Emmanuel Meyer i , Gilles Calais j , Didier Peiffert k , Benjamin Vandendorpe a , Estelle Aymes l , Cle´mence Leguillette l , Meryem Brihoum m , Soazig Nenan m , Luc Cormier n , Marie-Ce´cile Le Deley l , Eric F. Lartigau
doi : 10.1016/j.euo.2023.01.009
Volume 6, Issue 4, August 2023, Pages 399-405
Magnetic Resonance Imaging–based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification
Michael Baboudjian a,b,c,d,*, Bastien Gondran-Tellier c , Alae Touzani a , Alberto Martini a , Romain Diamand e , Jean-Baptiste Roche f , Vito Lacetera g , Jean-Baptiste Beauval a , Thierry Roumegue`re e , Guiseppe Simone h , Daniel Benamran i , Alexandre Fourcade j , Gaelle Fiard k , Roderick C.N. van den Bergh l , Alexandre Peltier e , Guillaume Ploussard
doi : 10.1016/j.euo.2022.09.005
Volume 6, Issue 4, August 2023, Pages 406-413
The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy
Carlo A. Bravi a,b,c,*, Paolo Dell’Oglio d,e,f , Elio Mazzone c , Marcio C. Moschovas g , Ugo Falagario h , Pietro Piazza a,i , Simone Scarcella a,j , Christopher Bednarz k , Luca Sarchi a , Stefano Tappero d,l , Sophie Knipper a,m , Ruben De Groote a,b , Daniel Sjoberg n , Riccardo Schiavina i , Nazareno Suardi l , Carlo Terrone l , Riccardo Autorino k , Giuseppe Carrieri h , Andrea Galosi j , Antonio Galfano d , Alberto Briganti c , Francesco Montorsi c , Vipul Patel g , Andrew Vickers n , Alexandre Mottrie
doi : 10.1016/j.euo.2022.06.010
Volume 6, Issue 4, August 2023, Pages 414-421
Quality Control Indicators for Transurethral Resection of Bladder Tumor: Results from an Embedded Belgian Multicenter Prospective Registry
Tim Muilwijk a , Murat Akand a , Yannic Raskin a , Cedric Jorissen a , Kathy Vander Eeckt b , Siska Van Bruwaene c , Ben Van Cleynenbreugel a , Steven Joniau a , Frank Van Der Aa
doi : 10.1016/j.euo.2022.11.005
Volume 6, Issue 4, August 2023, Pages 422-430
Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients with Muscle-invasive Bladder Cancer: A Retrospective Age-stratified Analysis on Safety and Efficacy
Gregory Hemenway a , Bianca Lewis b , Pooja Ghatalia b , Fern Anari b , Elizabeth R. Plimack b , Rutika Kokate b , Elizabeth Handorf b , Mengying Deng b , Daniel M. Geynisman b , Matthew Zibelman
doi : 10.1016/j.euo.2022.06.005
Volume 6, Issue 4, August 2023, Pages 431-436
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study
Viktor Gru¨nwald a,*, Thomas Powles b , Evgeny Kopyltsov c , Vadim Kozlov d , Teresa Alonso-Gordoa e , Masatoshi Eto f , Thomas Hutson g , Robert Motzer h , Eric Winquist i , Pablo Maroto j , Bhumsuk Keam k , Giuseppe Procopio l , Shirley Wong m , Bohuslav Melichar n , Frederic Rolland o , Mototsugu Oya p , Karla Rodriguez-Lopez q , Kenichi Saito r , Jodi McKenzie r , Camillo Porta
doi : 10.1016/j.euo.2023.01.010
Volume 6, Issue 4, August 2023, Pages 437-446
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma
Zeynep B. Zengin a,1, Ameish Govindarajan a,1, Nicholas Salgia a,1, Nicolas Sayegh b , Nishita Tripathi b , Ramya Muddasani a , Alex Chehrazi-Raffle a , Matthew Feng a , Benjamin D. Mercier a , Colton Ladbury c , Claire Hao c , Sabrina Salgia a , Neal Chawla a , Luis Meza a , Jasnoor Malhotra a , Nazli Dizman a , JoAnn Hsu a , Daniela V. Castro a , Regina Barragan-Carrillo d , Hedyeh Ebrahimi a , Errol J. Philip e , Mark Chang f , Jiaming Zhang g , Sara Byron g , Yung Lyou a , Tanya Dorff a , Sumanta K. Pal a,*,1, Savita Dandapani
doi : 10.1016/j.euo.2022.11.006
Volume 6, Issue 4, August 2023, Pages 447-450
Re: Bo Dai, Sheng Zhang, Fan-Ning Wan, et al. Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer : A Phase 2 Randomized Controlled Trial. Eur Urol Oncol 2022;5:519–25
Francesco Montorsi a,b Francesco Barletta a,b Giorgio Gandaglia
doi : 10.1016/j.euo.2023.01.006
Volume 6, Issue 4, August 2023, Page 451
